Oral administration of ferrous sulfate, but not of iron polymaltose or sodium iron ethylenediaminetetraacetic acid (NaFeEDTA), results in a substantial increase of non-transferrin-bound iron in healthy iron-adequate men.
about
Ferroportin mediates the intestinal absorption of iron from a nanoparticulate ferritin core mimetic in mice.Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study.Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans.Assessment of morphological and functional changes in organs of rats after intramuscular introduction of iron nanoparticles and their agglomerates.Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesCan Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?Can iron supplementation be reconciled with benefits and risks in areas hyperendemic for malaria?Differences in circulating non-transferrin-bound iron after oral administration of ferrous sulfate, sodium iron EDTA, or iron polymaltose in women with marginal iron stores.Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.Iron Absorption in Iron-Deficient Women, Who Received 65 mg Fe with an Indonesian Breakfast, Is Much Better from NaFe(III)EDTA than from Fe(II)SO₄, with an Acceptable Increase of Plasma NTBI. A Randomized Clinical Trial
P2860
Q33913185-2FF67052-D527-4F99-923C-84717CBFA082Q34056151-4F4CD042-317C-48AC-A469-A5078F65EA76Q34491984-989C3C79-9CD2-421B-A132-26CC84DC4045Q35151576-0B8DD81B-E41A-447A-B566-5E3A5B4CABD4Q35596454-FFFB0CB4-C128-4EF3-B31D-F8D08078C53CQ35920762-67224390-57E1-49EB-96A3-A3AFC5321ABFQ37394098-209156C1-E672-4107-9A07-547E77588EE2Q38156182-05E6937E-A3A0-4A6D-B6C2-28490583FDC5Q43883502-4FE3DF46-4423-4CE0-8E80-37F16671A5F5Q47821861-2A3524AC-D5AE-4567-B63F-CA782B5F7479Q58753485-9E23DE68-5C45-48FA-A9A4-C4396CE9453C
P2860
Oral administration of ferrous sulfate, but not of iron polymaltose or sodium iron ethylenediaminetetraacetic acid (NaFeEDTA), results in a substantial increase of non-transferrin-bound iron in healthy iron-adequate men.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Oral administration of ferrous ...... in healthy iron-adequate men.
@en
Oral administration of ferrous ...... in healthy iron-adequate men.
@nl
type
label
Oral administration of ferrous ...... in healthy iron-adequate men.
@en
Oral administration of ferrous ...... in healthy iron-adequate men.
@nl
prefLabel
Oral administration of ferrous ...... in healthy iron-adequate men.
@en
Oral administration of ferrous ...... in healthy iron-adequate men.
@nl
P2093
P1476
Oral administration of ferrous ...... in healthy iron-adequate men.
@en
P2093
Klaus Schümann
Maria-Eugenia Romero-Abal
Monica Orozco
Noel W Solomons
P304
P356
10.1177/156482651203300206
P577
2012-06-01T00:00:00Z